Graham Capital Management, L.P.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1315421 ROWAYTON, CT

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$340,260

+$33,934 QoQ

Shares Held

685

-0.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#1,187

of 1,735 holders

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Graham Capital Management, L.P. holds $44,243,780 across 71 Biotechnology names. VRTX ranks #18 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TVTX	Travere Therapeutics, Inc.	446,696	$25,376,799
2	INCY	Incyte Corp	15,632	$1,772,043
3	IONS	Ionis Pharmaceuticals Inc	16,717	$1,325,490
4	VKTX	Viking Therapeutics, Inc.	22,114	$862,667
5	ALNY	Alnylam Pharmaceuticals, Inc.	2,256	$679,123
6	ARVN	Arvinas, Inc.	81,364	$676,134
7	PCVX	Vaxcyte, Inc.	11,107	$645,649
8	MRVI	Maravai Lifesciences Holdings, Inc.	92,277	$575,808

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$340,260	685	-0.1%	Shares	Sole	2026-08-14
2026-03-31	$306,326	686	-42.5%	Shares	Sole	2026-05-15
2025-12-31	$540,858	1,193	+109.7%	Shares	Sole	2026-02-17
2024-12-31	$229,136	569	-75.9%	Shares	Sole	2025-02-14
2024-03-31	$985,249	2,357	+29.0%	Shares	Sole	2024-05-15
2023-12-31	$743,388	1,827	+59.7%	Shares	Sole	2024-02-14
2023-06-30	$402,585	1,144	-91.9%	Shares	Sole	2023-08-14
2022-09-30	$4,110,020	14,195	-0.6%	Shares	Sole	2022-11-14
2022-06-30	$4,024,806	14,283	+437.2%	Shares	Sole	2022-08-15
2022-03-31	$693,919	2,659	+9.2%	Shares	Sole	2022-05-16
2021-12-31	$534,945	2,436	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.